Evidence map›Paper›PMID 26939734›Full record

Observational studyThe lancet. HIV2016

A hybrid mobile approach for population-wide HIV testing in rural east Africa: an observational study.

Gabriel Chamie, Tamara D Clark, Jane Kabami, Kevin Kadede, Emmanuel Ssemmondo, Rachel Steinfeld, Geoff Lavoy, Dalsone Kwarisiima, Norton Sang, Vivek Jain and 9 more

3 registry-linked trialsOpen access · greenAbstract readObservational Study
In one paragraph

Observational study in The lancet. HIV, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to 3 registered trials, which are not on this map. Cited by 114 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
114citing papers in PubMed, 2 pooled it
18.3field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT01864603 nacompletednot on this map

Sustainable East Africa Research in Community Health

TypeinterventionalSponsorUniversity of California, San FranciscoRan2013 to 2021Enrolled150,395ConditionsHIV, Tuberculosis, Hypertension, DiabetesArmsUniversal ART in a streamlined care model, Annual Community Health Campaigns, Targeted PrEP and Targeted testing interventions, Baseline community-based HIV and multi-disease testing
NCT03135067 nacompletednot on this mapstarted 2017, after this paper: background citation

Secondary Distribution of HIV Self-tests: an Innovative Strategy for Promoting Partner Testing and Reducing HIV Risk

TypeinterventionalSponsorUniversity of PennsylvaniaRan2017 to 2020Enrolled2,102ConditionsHuman Immunodeficiency VirusArmsProvision of multiple self-tests
NCT04772469 nacompletednot on this mapstarted 2021, after this paper: background citation

Self-Test Strategies and Linkage Incentives to Improve ART and PrEP Uptake in Men

TypeinterventionalSponsorUniversity of California, San FranciscoRan2021 to 2023Enrolled934ConditionsHuman Immunodeficiency Virus, Acquired Immunodeficiency Syndrome, HIV Infections, Sexually Transmitted Diseases, ViralArmsProvision of multiple self-tests, Small monetary incentives, Use of SMS/text reminders to motivate adherence to ART or PrEP
3 · Its place in the literature

Who cites it

114 citing papers in PubMed, 2 syntheses or guidelines pooled it, 146 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Trial
  4. Trial
  5. SEARCH Human Immunodeficiency Virus (HIV) Streamlined Treatment Intervention Reduces Mortality at a Population Level in Men With Low CD4 Counts.Clinical infectious diseases : an official publication of the Infectious Diseases Society of America · 2021
    Trial
  6. Trial
  7. Trial
  8. Trial
  9. Trial
  10. Trial
  11. Trial
  12. Trial
  13. Trial
  14. Trial
  15. Trial
  16. Trial
  17. Trial
  18. Trial
  19. Early Adopters of Human Immunodeficiency Virus Preexposure Prophylaxis in a Population-based Combination Prevention Study in Rural Kenya and Uganda.Clinical infectious diseases : an official publication of the Infectious Diseases Society of America · 2018
    Trial
  20. Trial

54 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

19 authors at 6 institutions in 3 countries.

Gabriel ChamieDivision of HIV, Infectious Diseases and Global Medicine, San Francisco, CA, USA. Electronic address: gabriel.chamie@ucsf.edu.
Tamara D ClarkDivision of HIV, Infectious Diseases and Global Medicine, San Francisco, CA, USA.
Jane KabamiMakerere University-University of California Research Collaboration, Kampala, Uganda.
Kevin KadedeCentre for Microbiology Research, Kenya Medical Research Institute, Nairobi, Kenya.
Emmanuel SsemmondoMakerere University-University of California Research Collaboration, Kampala, Uganda.
Rachel SteinfeldDivision of HIV, Infectious Diseases and Global Medicine, San Francisco, CA, USA.
Geoff LavoyMakerere University-University of California Research Collaboration, Kampala, Uganda.
Dalsone KwarisiimaMakerere University-University of California Research Collaboration, Kampala, Uganda.
Norton SangCentre for Microbiology Research, Kenya Medical Research Institute, Nairobi, Kenya.
Vivek JainDivision of HIV, Infectious Diseases and Global Medicine, San Francisco, CA, USA.
Harsha ThirumurthyGillings School of Global Public Health, University of North Carolina at Chapel Hill, NC, USA.
Teri LieglerDivision of HIV, Infectious Diseases and Global Medicine, San Francisco, CA, USA.
Laura B BalzerDepartment of Biostatistics, Harvard T H Chan School of Public Health, Boston, MA, USA.
Maya L PetersenUniversity of California Berkeley School of Public Health, Berkeley, CA, USA.
Craig R CohenDepartment of Obstetrics, Gynecology and Reproductive Sciences, San Francisco, CA, USA.
Elizabeth A BukusiCentre for Microbiology Research, Kenya Medical Research Institute, Nairobi, Kenya.
Moses R KamyaDepartment of Medicine, School of Medicine, Makerere University College of Health Sciences, Kampala, Uganda.
Diane V HavlirDivision of HIV, Infectious Diseases and Global Medicine, San Francisco, CA, USA.
Edwin D CharleboisDepartment of Medicine, Center for AIDS Prevention Studies, University of California San Francisco, San Francisco, CA, USA.
Makerere University · UGKenya Medical Research Institute · KEBerkeley Public Health Division · USHarvard University · USUniversity of California, San Francisco · USUniversity of North Carolina at Chapel Hill · US

Funding

Virology CoreP30AI027763 · NIAID · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI STEVEN Grant DEEKS · 1988 to 2026
$93.6M
Ujima Mentoring ProgramP30MH062246 · NIMH · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI Sheri Ann Lippman · 2001 to 2026
$57.4M
Reducing Failure-to-Initiate ART: Streamlined ART Start Strategy (START)U01AI099959 · NIAID · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI HAVLIR, DIANE V · 2012 to 2016
$39.7M
San Francisco Vaccine and Prevention UnitUM1AI069496 · NIAID · PUBLIC HEALTH FOUNDATION ENTERPRISES · PI Susan Buchbinder, Diane V Havlir · 2012 to 2026
$30.5M
UCSF HIV Clinical Trials UnitUM1AI069502 · NIAID · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI HAVLIR, DIANE V · 2012 to 2013
$10.3M
Research Services CoreP2CHD050924 · NICHD · UNIV OF NORTH CAROLINA CHAPEL HILL · PI KAREN B GUZZO · 2015 to 2026
$9.6M
Targeted Learning using adaptive designs for HIV Epidemic control in East AfricaR01AI074345 · NIAID · UNIVERSITY OF CALIFORNIA BERKELEY · PI PETERSEN, MAYA LIV, VANDERLAAN, MARK J · 2007 to 2023
$6.6M
NIAID NIH HHS P30 AI027763NIAID NIH HHS R01 AI074345NIAID NIH HHS U01 AI099959NIAID NIH HHS U01AI099959NIAID NIH HHS UM1 AI069496NIAID NIH HHS UM1 AI069502NIAID NIH HHS UM1AI069502NICHD NIH HHS P2C HD050924NIMH NIH HHS P30 MH062246PEPFAR
6 · The paper itself

Abstract

backgroundDespite large investments in HIV testing, only an estimated 45% of HIV-infected people in sub-Saharan Africa know their HIV status. Optimum methods for maximising population-level testing remain unknown. We sought to show the effectiveness of a hybrid mobile HIV testing approach at achieving population-wide testing coverage.

methodsWe enumerated adult (≥15 years) residents of 32 communities in Uganda (n=20) and Kenya (n=12) using a door-to-door census. Stable residence was defined as living in the community for at least 6 months in the past year. In each community, we did 2 week multiple-disease community health campaigns (CHCs) that included HIV testing, counselling, and referral to care if HIV infected; people who did not participate in the CHCs were approached for home-based testing (HBT) for 1-2 months within the 1-6 months after the CHC. We measured population HIV testing coverage and predictors of testing via HBT rather than CHC and non-testing.

findingsFrom April 2, 2013, to June 8, 2014, 168,772 adult residents were enumerated in the door-to-door census. HIV testing was achieved in 131,307 (89%) of 146,906 adults with stable residence. 13,043 of 136,033 (9·6%, 95% CI 9·4-9·8) adults with and without stable residence had HIV; median CD4 count was 514 cells per μL (IQR 355-703). Among 131,307 adults with stable residence tested, 56,106 (43%) reported no previous testing. Among 13,043 HIV-infected adults, 4932 (38%) were unaware of their status. Among 105,170 CHC attendees with stable residence 104,635 (99%) accepted HIV testing. Of 131,307 adults with stable residence tested, 104,635 (80%; range 60-93% across communities) tested via CHCs. In multivariable analyses of adults with stable residence, predictors of non-testing included being male (risk ratio [RR] 1·52, 95% CI 1·48-1·56), single marital status (1·70, 1·66-1·75), age 30-39 years (1·58, 1·52-1·65 vs 15-19 years), residence in Kenya (1·46, 1·41-1·50), and migration out of the community for at least 1 month in the past year (1·60, 1·53-1·68). Compared with unemployed people, testing for HIV was more common among farmers (RR 0·73, 95% CI 0·67-0·79) and students (0·73, 0·69-0·77); and compared with people with no education, testing was more common in those with primary education (0·84, 0·80-0·89).

interpretationA hybrid, mobile approach of multiple-disease CHCs followed by HBT allowed for flexibility at the community and individual level to help reach testing coverage goals. Men and mobile populations remain challenges for universal testing.

fundingNational Institutes of Health and President's Emergency Plan for AIDS Relief.

Indexed as

Mobile Health UnitsAdultFemaleHealth PromotionHIV InfectionsHumansKenyaMaleMass ScreeningMiddle AgedUgandaYoung Adult

Identifiers

PMID26939734
PMCPMC4780220
OpenAlexW2251755465

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.